NAMA
CAI icon

Nikko Asset Management Americas’s Caris Life Sciences CAI Stock Holding History

Nikko Asset Management Americas’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Sell
33,883
-2,250
-6% -$40.3K 0.01% 180
2026
Q1 		$646K Sell
36,133
-18,586
-34% -$406K 0.01% 173
2025
Q4 		$1.48M Buy
54,719
+7,348
+16% +$207K 0.02% 145
2025
Q3 		$1.43M Buy
+47,371
New +$1.51M 0.01% 141

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nikko Asset Management Americas's CAI Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Caris Life Sciences (CAI) stake by 6.2% in Q2 2026, selling an estimated $40.3K and leaving 33,883 shares worth $603K. The position accounts for 0.01% of the portfolio, ranked #180.

Nikko Asset Management Americas first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.48M in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Nikko Asset Management Americas held 33,883 shares of Caris Life Sciences worth $603K as of Q2 2026.
  • Nikko Asset Management Americas sold 2,250 Caris Life Sciences shares in Q2 2026, an estimated $40.3K.
  • Caris Life Sciences made up 0.01% of Nikko Asset Management Americas's portfolio in Q2 2026, its #180 holding.
  • Nikko Asset Management Americas first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Nikko Asset Management Americas's Caris Life Sciences position peaked at $1.48M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.